| Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net | Clinical Infectious Diseases |  | | 2018 | 365 | 212 |
|
| Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others | The Journal of Law, Medicine & Ethics |  | | 2018 | 447 | 0 |
|
| Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires | Orphanet journal of rare diseases | | | 2015 | 608 | 1,718 |
|
| Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries | Orphanet journal of rare diseases | | | 2015 | 580 | 518 |
|
| Development of new antibiotics: taking off finally? | Schweizerische medizinische Wochenschrift | | | 2015 | 515 | 610 |
|
| Challenges and solutions for clinical development of new antibacterial agents: Results of a survey among pharmaceutical industry professionals | Antimicrobial agents and chemotherapy | | | 2015 | 586 | 1 |
|
| Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies | Future microbiology |  | | 2014 | 746 | 0 |
|
